- 米国企業
- Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc.DNA
時価総額
$159.5億
PER
2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Cell Engineering revenue | - | - | 144 |
Product | - | - | 29 |
Service | - | - | 79 |
Total revenue | - | - | 251 |
Product | - | - | 7 |
Service | - | - | 47 |
Research and development | - | - | 581 |
General and administrative | - | - | 385 |
Impairment of lease assets | - | - | 96 |
Total operating expenses | - | - | 1,116 |
Loss from operations | - | - | -864 |
Interest income | - | - | 57 |
Interest expense | - | - | 0 |
Loss on equity method investments | -77 | -44 | -3 |
Loss on investments | -12 | -53 | -55 |
Change in fair value of warrant liabilities | - | -125 | -5 |
Deconsolidation, Gain (Loss), Amount | - | 32 | -43 |
Other income (expense), net | - | - | 9 |
Total other income (expense), net | - | - | -29 |
Loss before income taxes | -1,838 | -2,121 | -893 |
Income tax benefit | - | - | -0 |
Net loss | - | -2,106 | -893 |
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders | - | -2,106 | -893 |
Earnings Per Share, Basic | - | - | -0.46 |
Earnings Per Share, Diluted | - | - | -0.46 |
Net loss | - | -2,106 | -893 |
Foreign currency translation adjustment | - | - | 4 |
Total other comprehensive gain (loss) | - | - | 4 |
Comprehensive loss | - | - | -889 |